Online citations, reference lists, and bibliographies.
← Back to Search

Advances In The Design Of Solid Lipid Nanoparticles And Nanostructured Lipid Carriers For Targeting Brain Diseases

C. Tapeinos, Matteo Battaglini, G. Ciofani
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
&NA; Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) comprise a category of versatile drug delivery systems that have been used in the biomedical field for >25 years. SLNs and NLCs have been used for the treatment of various diseases including cardiovascular and cerebrovascular, and are considered a standard treatment for the latter, due to their inherent ability to cross the blood brain barrier (BBB). In this review, a presentation of the most important brain diseases (brain cancer, ischemic stroke, Alzheimer's disease, Parkinson's disease and multiple sclerosis) is approached, followed by the basic fabrication techniques of SLNs and NLCs. A detailed description of the reported studies of the last seven years, of active and passive targeting SLNs and NLCs for the treatment of glioblastoma multiforme and of other brain cancers, as well as for the treatment of neurodegenerative diseases is also carried out. Finally, a brief description of the advantages, the disadvantages, and the future perspectives in the use of these nanocarriers is reported, aiming at giving an insight of the limitations that have to be overcome in order to result in a delivery system with high therapeutic efficacy and without the limitations of the existing nano‐systems. Graphical abstract A multi‐functional nanostructured lipid carrier (M‐NLC) can penetrate the blood brain barrier (BBB) after proper surface functionalization and deliver its therapeutic cargo in the diseased tissue. Figure. No caption available.
This paper references
10.1155/2013/238428
Nanoparticles for Brain Drug Delivery
M. Masserini (2013)
10.1016/j.ejphar.2014.11.014
Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence.
Anand Kamal Sachdeva (2015)
10.3109/1061186X.2014.940589
Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier
Y. Yang (2014)
10.3923/IJP.2009.90.93
Solid lipid nanoparticles preparation and characterization.
Nagi A. Alhaj (2009)
10.1248/CPB.58.656
Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
Chun-rong Yang (2010)
10.1016/j.ijpharm.2012.12.013
Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems.
S. Bose (2013)
10.1016/J.EJPB.2014.10.017
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
D. Chirio (2014)
10.2147/IJN.S36257
In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration
M. Fang (2012)
10.1155/2014/816103
Niosomes of Ascorbic Acid and α-Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats
J. Varshosaz (2014)
10.1074/jbc.M113.476697
α-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles*
J. Varkey (2013)
10.1021/nn506248s
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Z. Cohen (2015)
10.1038/nnano.2014.84
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
James E. Dahlman (2014)
10.1016/j.ejpb.2011.02.009
Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration.
L. Priano (2011)
10.1016/j.lfs.2016.01.025
Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
Y. Kuo (2016)
10.1208/s12249-012-9862-8
The Improvement of the Anticancer Effect of a Novel Compound Benzoic Acid, 2-Hydroxy-, 2-d-ribofuranosylhydrazide (BHR) Loaded in Solid Lipid Nanoparticles
M. Wang (2012)
10.15171/apb.2015.043
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Neda Naseri (2015)
10.1517/17425247.2014.945416
Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy
Tausif Alam (2015)
56 G
R. Campardelli (2013)
10.2217/nnm.09.67
Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
M. Bondì (2010)
10.1016/j.ijpharm.2012.07.058
Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
A. Silva (2012)
10.3109/02652048.2011.590615
Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique
D. Chirio (2011)
10.1016/j.neulet.2015.06.049
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis
Tobias Führmann (2015)
10.1016/j.jpsychires.2012.05.014
Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain.
M. I. Alam (2012)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
10.3389/fnagi.2016.00068
Lipopolyplex for Therapeutic Gene Delivery and Its Application for the Treatment of Parkinson’s Disease
Wei Chen (2016)
10.1039/C2TB00013J
Microspheres as therapeutic delivery agents: synthesis and biological evaluation of pH responsiveness.
C. Tapeinos (2013)
10.1016/j.nano.2015.09.004
Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
A. Beloqui (2016)
10.1016/j.ijpharm.2013.02.014
Comparative in vitro and in vivo evaluation of lipid based nanocarriers of Huperzine A.
Pratikkumar A. Patel (2013)
10.1111/j.2042-7158.2010.01225.x
Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery
S. Dhawan (2011)
Niosomes as Nanoparticular Drug Carriers : Fundamentals and Recent Applications
D. A. Şeleci (2016)
10.1515/9783111697888-004
B
B. A. R. Kernfach (1824)
10.3389/fbioe.2016.00049
Biomaterials for the Treatment of Alzheimer’s Disease
D. Hadavi (2016)
10.3389/fnagi.2015.00020
Retinoic acid-loaded polymeric nanoparticles induce neuroprotection in a mouse model for Parkinson's disease
Marta Esteves (2015)
10.1111/j.1755-5949.2010.00199.x
Nanoparticulate Systems for Drug Delivery and Targeting to the Central Nervous System
E. Craparo (2011)
10.4103/2277-9175.98152
Viral and nonviral delivery systems for gene delivery
Nouri Nayerossadat (2012)
10.1016/S0939-6411(97)00172-0
Spray-drying of solid lipid nanoparticles (SLN TM).
C. Freitas (1998)
10.1038/nrc.2016.108
Cancer nanomedicine: progress, challenges and opportunities
J. Shi (2017)
10.1111/J.1551-2916.2007.02240.X
Synthesis and Characterization of Magnetic Nanocontainers
C. Tapeinos (2008)
10.1097/PPO.0b013e318244d8ae
Novel Delivery Strategies for Glioblastoma
J. Zhou (2012)
10.1080/10837450.2016.1189933
Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box–Behnken design
J. Emami (2017)
10.1111/bcp.12170
Clinical pharmacology = disease progression + drug action
N. Holford (2015)
10.2217/nnm.14.130
Applications of dendrimers for brain delivery and cancer therapy.
Sukrut Somani (2014)
10.1016/j.ijpharm.2011.05.044
Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
R. Tiwari (2011)
10.1007/s40089-015-0161-8
Development of nanostructured lipid carrier for dacarbazine delivery
Musallam Almousallam (2015)
10.3109/1061186X.2010.523787
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
S. Patel (2011)
Lipopolyplex for therapeutic gene delivery and sci
W. Chen (2016)
10.3390/ph9030054
Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting—Ideal Versus Reality
C. Y. Lee (2016)
10.1016/B978-0-7020-7222-2.00022-6
V
M. Millodot (2018)
10.1016/j.colsurfb.2017.07.081
Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers.
J. Bizeau (2017)
10.1002/jps.24002
Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Luigi Battaglia (2014)
10.1186/1556-276X-9-538
Potential applications of magnetic particles to detect and treat Alzheimer's disease
M. Busquets (2014)
Liposomes for Targeted Delivery of Active Agents against Drug Deliv
C. Spuch (2011)
10.1155/2016/7372306
Niosomes as Nanoparticular Drug Carriers
D. A. Şeleci (2016)
10.1016/j.ejps.2012.05.010
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
S. Das (2012)
10.3389/fphar.2013.00157
The potential of polymeric micelles in the context of glioblastoma therapy
R. Morshed (2013)
10.1016/j.ijpharm.2011.07.040
Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
J. Pardeike (2011)
10.1021/acsnano.5b03124
GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
Meng Huang (2015)
10.1016/j.ijpharm.2014.08.003
In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
S. Jose (2014)
10.1016/j.biomaterials.2010.04.044
Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.
M. Gobbi (2010)
10.1016/j.jcis.2015.03.019
CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
J. Zhao (2015)
10.1002/btpr.2214
Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy
Y. Kuo (2016)
10.1016/j.ijpharm.2016.04.033
Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
Fanfei Meng (2016)
10.1088/0957-4484/21/40/405101
Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Shu-Hui Hsu (2010)
10.1515/9783111576855-009
D
Saskia Bonjour (1824)
10.1016/J.JTICE.2015.12.012
Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy
Y. Kuo (2016)
10.1016/j.nano.2013.10.009
Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats.
Yingzheng Zhao (2014)
10.3109/03639045.2013.861478
Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB
Zhidong Liu (2015)
10.2147/IJN.S117210
Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
D. B. Vieira (2016)
10.2174/187152711796235023
Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain.
S. Beg (2011)
10.1038/nrd3578
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
M. Lobatto (2011)
10.1002/anie.201203780
Ceria nanoparticles that can protect against ischemic stroke.
C. K. Kim (2012)
10.1001/ARCHNEUR.1989.00520420080026
Interrater reliability of the NIH stroke scale.
L. Goldstein (1989)
10.1016/J.ADDR.2012.09.021
Solid lipid nanoparticles
W. Mehnert (2012)
10.1016/j.ejpb.2013.08.011
Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
S. Martins (2013)
10.1002/jps.24388
Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
Y. Kuo (2015)
10.1016/S0378-5173(02)00180-1
Nanostructured lipid matrices for improved microencapsulation of drugs.
R. Mueller (2002)
10.1038/nrendo.2015.35
Cardiovascular disease: New nanomedicines for treating atherosclerotic plaques
J. Sargent (2015)
European Journal of Ejpmr Transfersomes : Novel Approach for Intranasal Delivery
S. Chaurasia (2017)
10.1515/9783111413426-013
L
Il Liceo (1824)
10.3109/10717544.2015.1028601
A smart tumor targeting peptide–drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells
Q. Song (2016)
10.2147/IJN.S15881
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
S. Eskandari (2011)
10.1002/adma.201505376
Physical, Chemical, and Biological Structures based on ROS-Sensitive Moieties that are Able to Respond to Oxidative Microenvironments.
C. Tapeinos (2016)
10.1515/9783486731620-002
I
John B. Shoven (1824)
10.1016/j.canlet.2012.07.006
A critical review of lipid-based nanoparticles for taxane delivery.
L. Feng (2013)
Pharmacological Treatment of Parkinson Disease, Jama
S. Connolly Barbara (2014)
Dynamic in vivo imaging of dual-triggered microspheres for sustained release applications
Ελένη Κ. Ευθυμιάδου (2015)
Method for producing solid lipid microspheres having a naroww size distribution
M. R. Gasco (1993)
66 G
L. Montenegro (2011)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
10.17795/JJNPP-33968
Superoxide Dismutase-Loaded Solid Lipid Nanoparticles Prepared by Cold Homogenization Method: Characterization and Permeation Study Through Burned Rat Skin
M. Karami (2016)
10.1016/j.ijpharm.2015.03.001
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization.
S. Laserra (2015)
10.1016/j.ijpharm.2015.04.049
Effect of Baicalin-loaded PEGylated cationic solid lipid nanoparticles modified by OX26 antibody on regulating the levels of baicalin and amino acids during cerebral ischemia-reperfusion in rats.
Zhidong Liu (2015)
10.1007/S11051-011-0579-5
New approach in synthesis, characterization and release study of pH-sensitive polymeric micelles, based on PLA-Lys-b-PEGm, conjugated with doxorubicin
E. K. Efthimiadou (2011)
10.2174/1568015023357950
Transport of Drugs Across the Blood-Brain Barrier by Nanoparticles
J. Kreuter (2002)
10.1016/j.jare.2016.03.002
Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.
N. Shah (2016)
10.1016/j.ijpharm.2010.05.005
Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
Chun-Yang Zhuang (2010)
10.1016/j.jconrel.2016.05.044
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
C. Saraiva (2016)
10.1016/j.addr.2011.12.006
Polymeric nanoparticles for drug delivery to the central nervous system.
T. Patel (2012)
10.1208/s12248-015-9780-2
A Review of Clinical Translation of Inorganic Nanoparticles
Aaron C. Anselmo (2015)
10.1016/j.colsurfb.2016.08.019
Sustained release profile of quatro stimuli nanocontainers as a multi sensitive vehicle exploiting cancer characteristics.
C. Tapeinos (2016)
10.1039/C5RA19793G
Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment
S. Singh (2016)
Cavallaro Gennara
E. F. Craparo (2011)
10.3109/1061186X.2012.747529
Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model
Mohammad Yusuf (2013)
10.1097/01376517-200710000-00005
Acute Ischemic Stroke Review
J. Hinkle (2007)
10.1016/j.jconrel.2017.05.019
Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease
M. Agrawal (2017)
10.1093/hmg/dds496
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
P. M. Costa (2013)
10.1016/J.AJPS.2016.01.001
Spray drying of fenofibrate loaded nanostructured lipid carriers
Dengning Xia (2016)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.1038/NATREVMATS.2016.14
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm (2016)
10.1016/j.nano.2012.03.003
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles.
Vinay Kumar Venishetty (2013)
10.1016/j.colsurfb.2013.11.029
Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers.
Liang Liu (2014)
10.1021/mp300149w
Idebenone loaded solid lipid nanoparticles interact with biomembrane models: calorimetric evidence.
L. Montenegro (2012)
10.1039/C6RA00423G
An acetal-based polymeric crosslinker with controlled pH-sensitivity
Hongliang Cao (2016)
10.1016/j.ijpharm.2012.09.054
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
S. Martins (2012)
10.1002/jps.22285
Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: pharmacokinetic and behavioral evaluations.
Ming-Jun Tsai (2011)
10.1016/j.ijpharm.2012.03.042
Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
Guo Chen-yu (2012)
10.1016/j.ijpharm.2011.12.009
Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Ming-Jun Tsai (2012)
10.1002/wnan.1308
Learning from biology: synthetic lipoproteins for drug delivery.
H. Huang (2015)
10.4155/tde.13.101
Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential.
Leenata Mandpe (2013)
10.1021/bc200406n
In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
Juyoun Jin (2011)
10.1080/10837450.2016.1226901
Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines
Nargess Gandomi (2017)
10.1166/JNN.2011.4235
Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia.
P. Sharma (2011)
10.3390/nano6040076
Multifunctional Inorganic Nanoparticles: Recent Progress in Thermal Therapy and Imaging
Kondareddy Cherukula (2016)
Ajazuddin
M. Agrawal (2017)
10.1016/j.msec.2014.01.024
pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies.
E. K. Efthimiadou (2014)
10.1002/9781119041450
Handbook of Polymers for Pharmaceutical Technologies: Biodegradable Polymers
V. Thakur (2015)
10.1016/j.ejpb.2009.09.003
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
S. Gelperina (2010)
10.3109/10717544.2014.975382
Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study
Rohini G Madane (2016)
10.1016/j.addr.2013.08.008
Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?
J. Kreuter (2014)
10.3109/10837450.2014.915572
Antioxidant activity of idebenone-loaded neutral and cationic solid–lipid nanoparticles
A. Leonardi (2015)
10.1021/cn400182z
Dendrimer advances for the central nervous system delivery of therapeutics.
L. Xu (2014)
10.1016/J.ADDR.2007.05.004
Lipid nanoparticles: perspectives and challenges.
M. Gasco (2007)
Thaxton, Synthetic High-Density Lipoprotein-Like Nanoparticles
K. M. McMahon (2015)
10.3109/03639045.2011.608191
Nanostructure-based drug delivery systems for brain targeting
S. Haque (2012)
Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism
R. Parhi (2010)
10.1016/j.biomaterials.2011.01.048
Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
Y. Kuo (2011)
10.1016/j.nano.2017.03.015
Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides.
Li Jin (2017)
10.1016/J.JTICE.2014.08.035
Carmustine-loaded catanionic solid lipid nanoparticles with serotonergic 1B receptor subtype antagonist for in vitro targeted delivery to inhibit brain cancer growth
Y. Kuo (2015)
10.1016/J.SUPFLU.2013.05.020
Lipid nanoparticles production by supercritical fluid assisted emulsion–diffusion
R. Campardelli (2013)
10.1088/0957-4484/23/40/405101
Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.
Amir Khajavinia (2012)
10.1016/S0140-6736(11)61346-9
Primary brain tumours in adults
D. Ricard (2012)
Gold-nanoparticle-based multifunctional amyloid- - A Eur
N. Gao (2015)
60 Multiple sclerosis: Therapeutic applications of advancing drug delivery systems
S. Dolati (2017)
10.2147/IJN.S87148
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Bruno Fonseca-Santos (2015)
10.1016/j.dib.2015.11.038
Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method
D. Pooja (2016)
10.1016/j.biopha.2016.12.010
Multiple sclerosis: Therapeutic applications of advancing drug delivery systems.
S. Dolati (2017)
10.1515/9783111548050-024
M
M. Sankar (1824)
10.1016/j.ejpb.2013.02.005
Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.
V. Kakkar (2013)
10.1073/pnas.1701911114
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
D. Yu (2017)
10.1016/j.jconrel.2011.07.030
In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
A. Estella-Hermoso de Mendoza (2011)
10.1016/j.jconrel.2015.06.002
PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
C. Fornaguera (2015)
10.1371/journal.pone.0062425
Selective Targeting of Brain Tumors with Gold Nanoparticle-Induced Radiosensitization
D. Joh (2013)
10.4103/0975-7406.130965
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
Kanika Madaan (2014)
10.1007/s11883-010-0106-7
Insights into Atherosclerosis Using Nanotechnology
A. Jayagopal (2010)
10.1016/j.ijpharm.2014.07.025
Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
Yasmine M Gabal (2014)
10.3109/10717544.2015.1038857
Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy
Z. Chen (2016)
10.3109/03639045.2010.539231
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Lucia Montenegro (2011)
10.3389/fphar.2017.00751
Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study
J. Meyer (2017)
10.1016/j.ijpharm.2015.12.054
Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
Y. Kuo (2016)
10.2147/IJN.S60853
Antioxidative nanofullerol prevents intervertebral disk degeneration
Xinlin Yang (2014)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1016/j.biomaterials.2013.09.093
Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles.
Y. Lu (2014)
10.1016/j.colsurfb.2011.02.011
Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells.
Y. Kuo (2011)
10.3389/fchem.2014.00109
The application of magnetic nanoparticles for the treatment of brain tumors
K. Mahmoudi (2014)
X
L. Jin (2017)
10.1016/j.nano.2017.03.022
Functionalised collagen spheres reduce H2O2 mediated apoptosis by scavenging overexpressed ROS.
C. Tapeinos (2018)
10.1021/nl2025882
Nanoparticles targeting the infarcted heart.
Tal Dvir (2011)
10.1016/j.colsurfb.2015.06.025
A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
Fanfei Meng (2015)
10.1016/S0140-6736(05)79943-8
Physical
J. Graham-Pole (1998)
10.1007/s10856-013-4965-7
Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation
C. Pardeshi (2013)
10.1088/0957-4484/23/9/095103
Combined strategies of apomorphine diester prodrugs and nanostructured lipid carriers for efficient brain targeting.
Kuo-Sheng Liu (2012)
10.1016/j.ijpharm.2012.03.032
Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway.
S. Martins (2012)
10.1016/j.ejpb.2012.10.019
Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment.
A. Zanotto-Filho (2013)
10.3109/10717544.2015.1064186
Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy
Shuxin Song (2016)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1088/0957-4484/26/25/255102
Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies.
L. Battaglia (2015)
10.3109/10837450.2012.734513
Brain targeted solid lipid nanoparticles for brain ischemia: preparation and in vitro characterization
N. Morsi (2013)
10.1021/acs.chemrev.5b00046
New Developments in Liposomal Drug Delivery.
Bhushan S. Pattni (2015)
X
Y. Z. Zhao (2014)
Lipoprotein-based nanoparticles disease by accelerating the clearance of amyloid-beta
Q. Song (2014)
10.1002/9781119247159.CH6
Nanostructured Lipid Carriers
Jingyuan Wen (2018)
10.1007/978-3-319-16555-4_6
Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.
K. M. McMahon (2015)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1016/j.npep.2016.03.002
Mitigating effect of chrysin loaded solid lipid nanoparticles against Amyloid β25–35 induced oxidative stress in rat hippocampal region: An efficient formulation approach for Alzheimer's disease
Aishwarya Vedagiri (2016)
10.1080/10717544.2016.1189465
Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
J. Qu (2016)
10.1155/2011/469679
Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
C. Spuch (2011)
Bevacizumab loaded solid lipid nanoparticles ACCEPTED MANUSCRIPT AC C EP TE D M AN U SC R IP T 57 prepared by the coacervation technique: preliminary in vitro studies
L. Battaglia (2015)
10.1016/j.ijpharm.2013.03.046
Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain.
V. Kakkar (2013)
10.3389/fnagi.2016.00001
Amidated and Ibuprofen-Conjugated Kyotorphins Promote Neuronal Rescue and Memory Recovery in Cerebral Hypoperfusion Dementia Model
Sónia Sá Santos (2016)
10.3109/10717544.2015.1049719
Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo
Y. Chen (2016)
10.1039/C4BM00441H
Micro- and Nanoparticles for Treating Cardiovascular Disease.
S. Suarez (2015)
10.1111/j.1365-2796.2009.02189.x
Lipid‐based nanotherapeutics for siRNA delivery
A. Schroeder (2010)
10.1016/j.geb.2003.09.006
Preparation
M. Voorneveld (2004)
10.2147/IJN.S40284
The antiproliferative effect of indomethacin-loaded lipid-core nanocapsules in glioma cells is mediated by cell cycle regulation, differentiation, and the inhibition of survival pathways
A. Bernardi (2013)
10.1007/s11095-010-0141-7
Nanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and Diagnosis
H. Yang (2010)
10.1002/chem.201404562
Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
N. Gao (2015)
In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for pharmacological effects
M. Fang (2012)
10.3389/fnagi.2015.00016
Bone mineral density, adiposity, and cognitive functions
H. Sohrabi (2015)
10.1016/J.ADDR.2006.09.012
Brain cancer diagnosis and therapy with nanoplatforms.
Y. Koo (2006)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1007/BF03075138
Global prevalence of dementia: a Delphi consensus study
      (2006)
Biomaterials f Front
D. Hadavi (2016)
10.1001/jama.2014.3654
Pharmacological treatment of Parkinson disease: a review.
B. Connolly (2014)
10.3109/03639040903264397
Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers
Fang Li (2010)
10.1016/J.TRAC.2015.12.016
Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems
J. E. N. Dolatabadi (2016)
10.1016/j.ejpb.2013.08.013
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
S. Weber (2014)
10.1016/j.biochi.2011.05.005
Functional lipids and lipoplexes for improved gene delivery.
Xiaoxiang Zhang (2012)
10.1016/j.ijpharm.2013.05.049
Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death.
A. Griveau (2013)
10.1016/j.brainresrev.2010.05.003
Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
F. L. Cardoso (2010)
10.3109/10717544.2015.1058434
Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery
Miaojing Wu (2016)
10.1208/s12248-012-9330-0
Challenges in Development of Targeted Liposomal Therapeutics
R. Sawant (2012)
10.1248/BPB.34.945
Niosomes: a controlled and novel drug delivery system.
Rampal Rajera (2011)
10.3389/fphar.2017.00166
Targeted Nanotechnology in Glioblastoma Multiforme
T. Glaser (2017)
10.3109/1061186X.2015.1132223
Enhanced delivery of etoposide across the blood–brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles
Y. Kuo (2016)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
10.1016/0021-9797(68)90272-5
Controlled growth of monodisperse silica spheres in the micron size range
W. Stoeber (1968)
10.1021/nn4058215
Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer's disease by accelerating the clearance of amyloid-beta.
Qingxiang Song (2014)
Brain targeting effect of camptothecin- loaded solid lipid nanoparticles in rat after ACCEPTED MANUSCRIPT AC C EP TE D M AN U SC R IP T 56 intravenous administration
S. M. Martins (2013)
Niosomes -Tocopherol in the Cerebral Ischemia-Reperfusion Model in Male Rats
J. Varshosaz (2014)
10.1016/j.ejps.2010.03.019
Gene delivery by lipoplexes and polyplexes.
C. Tros de Ilarduya (2010)
Guanci, Acute ischemic stroke review
M.M.J.L. Hinkle (2007)
10.1016/j.ijpharm.2014.02.013
A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Congcong Lin (2014)



This paper is referenced by
10.2147/IJN.S274352
Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment
Randa Hanie Awadeen (2020)
10.1016/j.addr.2019.01.012
A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders.
J. Samal (2019)
10.3390/ph13090255
Eluxadoline Loaded Solid Lipid Nanoparticles for Improved Colon Targeting in Rat Model of Ulcerative Colitis
Md Khalid Anwer (2020)
10.1007/978-3-030-36260-7_6
Synthetic, Natural Derived Lipid Nanoparticles and Polymeric Nanoparticles Drug Delivery Applications
K. Mohanrasu (2020)
10.1016/j.ijpharm.2020.119655
Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer.
A. Groo (2020)
10.1016/j.colsurfb.2018.03.052
Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
S. Scioli Montoto (2018)
10.1007/978-3-030-39246-8_3
Nanotoxicology in Plants
B. Millán-Chiu (2020)
10.1002/PI.5674
Encapsulation of hydrophobic vitamins by polylactide stereocomplexation and their release study
Edyta Wojtczak (2018)
DEVELOPMENT, EVALUATION AND TARGETING OF IMATINIB MESYLATE LOADED SOLID LIPID NANOPARTICLES TO THE LYMPHATIC SYSTEM
Raju Vivek (2018)
10.3390/pharmaceutics12060587
Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
Agata Pucek (2020)
10.1055/s-0039-3399568
Applications of Nanotechnology in the Diagnosis and Therapy of Stroke.
Lila Landowski (2019)
10.2217/nnm-2018-0436
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
A. Grillone (2019)
10.1016/j.addr.2018.10.011
Neurotheranostics as personalized medicines.
B. Kevadiya (2018)
10.3390/pharmaceutics12090860
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme
Raneem Jnaidi (2020)
10.1016/j.xphs.2018.07.008
Improving Dissolution Properties by Polymers and Surfactants: A Case Study of Celastrol.
Jun Zha (2018)
10.3390/brainsci10060333
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis
Olga Kammona (2020)
10.3762/bjnano.11.72
Key for crossing the BBB with nanoparticles: the rational design
S. Lombardo (2020)
10.3390/biom10101401
The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
Bikram Khadka (2020)
10.1007/978-3-030-30930-5_7
Nanobiotechnology in Parkinson’s Disease
Pablo Vicente Torres-Ortega (2019)
10.1038/s41568-019-0205-x
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
C. Arvanitis (2019)
10.3390/medicines6010007
Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations
Elena Giuliano (2018)
10.3390/nano8020110
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative
B. Stella (2018)
10.5772/INTECHOPEN.88412
Self-Emulsifying Drug Delivery Systems: Easy to Prepare Multifunctional Vectors for Efficient Oral Delivery
K. AboulFotouh (2019)
10.1002/adma.201902604
Ligand-Installed Nanocarriers toward Precision Therapy.
P. Mi (2019)
10.1208/s12249-018-1078-0
Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles
J. Silva (2018)
10.1016/j.colsurfb.2020.111209
Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model.
Isra Rana (2020)
10.1208/s12249-020-01795-w
Quality by Design Adapted Chemically Engineered Lipid Architectonics for HIV Therapeutics and Intervention: Contriving of Formulation, Appraising the In vitro Parameters and In vivo Solubilization Potential.
Bushra Nabi (2020)
10.2147/IJN.S236968
A Correlative Imaging Study of in vivo and ex vivo Biodistribution of Solid Lipid Nanoparticles
S. Mannucci (2020)
10.1039/d0tb00262c
Fluorescence resonance energy transfer-based drug delivery systems for enhanced photodynamic therapy.
Y. Huang (2020)
10.3389/fchem.2020.589957
Application of Functional Biocompatible Nanomaterials to Improve Curcumin Bioavailability
Ziyun Li (2020)
10.1016/j.colsurfb.2019.110446
Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice.
W. Du (2019)
10.2147/IJN.S247935
Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery
Y. Sun (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar